Study to Evaluate the Effects of Age & Gender on PK, Safety & Tolerability of HCV-796 Administered to Healthy Subjects

Phase 1 Completed 48 enrolled Wyeth is now a wholly owned subsidiary of Pfizer ViroPharma · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study is an open-label, single-dose, parallel group study to evaluate the effects of age and gender on the pharmacokinetics, safety, and tolerability of HCV-796 administered orally to healthy subjects.

Timeline

Start: 2006-11
Primary completion: 2007-06
Completion: 2007-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	NESBUVIR	Small molecule	1000 mg	Oral

Indications

No indication recorded.